In a recent follow-up study, researchers discovered that when used as a dietary supplement, choline was able to reduce symptoms associated with Alzheimer’s disease in female mice.
New insights indicate a role for the microbiome in Alzheimer’s and Parkinson’s diseases and point towards new treatment avenues.
Research consortium ‘LipDiDiet’ reports 24-month clinical trials results, showing that Souvenaid did not improve performance in neuropsychological test battery, but did reduce brain shrinkage and cognitive decline in prodromal AD patients.
Findings from four large, population-based studies have further confirmed the importance of good dietary practices in maintaining healthy brain function and reducing dementia risk.
Participants in the top 25% for estimated annual mercury intake had a twofold higher risk of developing amyotrophic lateral sclerosis.
New research demonstrates that a vitamin A deficiency whilst in the womb may contribute to Alzheimer’s disease later on in life, but that this could be reversed in newborns with vitamin supplements.
In this report the authors explore the potential role of IGF2 methylation and the development of brain regions implicated in ADHD.
Researchers from Purdue University (West Lafayette, IN, USA) have observed that drinking highly caffeinated alcoholic beverages elicits changes in the adolescent brain similar to taking cocaine.
Utilizing data from a study into amyotrophic lateral sclerosis (ALS) progression, a team of researchers has examined associations between nutritional intake, function and respiratory function.
Researchers have suggested that diet and gut flora influence neuroinflammation and may play a role in the progression of multiple sclerosis.